Component
Human carnosine synthase / CARNS1 (ATPGD1)
Context-specific entity; species, compartment and exposure are stated on each claim.
3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Stable carnosine-synthase expression in human SH-SY5Y cells was associated with 2-oxo-carnosine formation and less peroxide cytotoxicity.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human neuroblastoma expression model.
- limitations
- Does not isolate 2-oxo-carnosine as the only protective mediator.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- Increasing synthesis changed the cellular response to an oxidant.
- primary_references
- 2-Oxo-histidine-containing dipeptides are functional oxidation products. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30504220/ · DOI 10.1074/jbc.RA118.006111
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 348–354
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human neuroblastoma expression model. · source_derived_draft · unverified_draft
## carnosine-carns1-cell-protection Increasing synthesis changed the cellular response to an oxidant. Stable carnosine-synthase expression in human SH-SY5Y cells was associated with 2-oxo-carnosine formation and less peroxide cytotoxicity. Model: Human neuroblastoma expression model. Limitations: Does not isolate 2-oxo-carnosine as the only protective mediator. Evidence access: Primary abstract 2-Oxo-histidine-containing dipeptides are functional oxidation products. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30504220/ · DOI 10.1074/jbc.RA118.006111
Complete structured claim and evidencePurified human CARNS1 also synthesized homocarnosine using GABA, with lower catalytic efficiency than the beta-alanine reaction.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Recombinant human enzyme substrate comparison.
- limitations
- Shared synthesis does not mean the two peptides have identical functions.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- The same enzyme can assemble a related GABA-containing peptide.
- primary_references
- Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). · 2010 · https://pubmed.ncbi.nlm.nih.gov/20097752/ · DOI 10.1074/jbc.M109.095505
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 36–42
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human enzyme substrate comparison. · source_derived_draft · unverified_draft
## carnosine-homocarnosine The same enzyme can assemble a related GABA-containing peptide. Purified human CARNS1 also synthesized homocarnosine using GABA, with lower catalytic efficiency than the beta-alanine reaction. Model: Recombinant human enzyme substrate comparison. Limitations: Shared synthesis does not mean the two peptides have identical functions. Evidence access: Primary abstract Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). · 2010 · https://pubmed.ncbi.nlm.nih.gov/20097752/ · DOI 10.1074/jbc.M109.095505
Complete structured claim and evidencePurified recombinant human CARNS1 joined beta-alanine and L-histidine to form carnosine in an ATP-containing assay.
Experimental context and source evidence
- evidence_access
- Primary abstract and full-text enzyme methods
- experimental_model
- Human enzyme expressed in HEK293T cells.
- limitations
- An enzyme assay does not define dietary requirements.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- Two building blocks are assembled by a specific enzyme.
- primary_references
- Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). · 2010 · https://pubmed.ncbi.nlm.nih.gov/20097752/ · DOI 10.1074/jbc.M109.095505
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 20–26
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human enzyme expressed in HEK293T cells. · source_derived_draft · unverified_draft
## carnosine-synthesis Two building blocks are assembled by a specific enzyme. Purified recombinant human CARNS1 joined beta-alanine and L-histidine to form carnosine in an ATP-containing assay. Model: Human enzyme expressed in HEK293T cells. Limitations: An enzyme assay does not define dietary requirements. Evidence access: Primary abstract and full-text enzyme methods Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). · 2010 · https://pubmed.ncbi.nlm.nih.gov/20097752/ · DOI 10.1074/jbc.M109.095505
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.